Device Trial Radar · NCT04313725
Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
28
Actual
Start
Feb 24, 2020
Primary completion
Jun 21, 2023
Study completion Jun 21, 2023
Sponsor
- Lead sponsor
- Tangible ScienceNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Boston Sight
- First posted
- Mar 18, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this research is to determine if the Tangible Boost system adequately replenishes the Hydra-PEG coating on the surface of a rigid contact lens. Hydra-PEG is a coating for soft and rigid contact lens, primarily composed of polyethylene glycol-based hydrogel, which is covalently bound to the surface of a contact lens. The Hydra-PEG coating is intended to improve wettability and comfort with contact lenses and is currently FDA approved on a number of contact lenses. For patients with Stevens Johnson Syndrome (SJS) (SS), or Graft versus Host disease (GVHD), diminished efficacy of the Hydra-PEG coating can lead to significant decline in satisfaction with the lenses over time. This is a prospective study to evaluate the efficacy of Tangible Boost, a monthly conditioning solution, to replenish the Hydra-PEG coating on rigid gas permeable contact lenses for patients with SJS, GVHD, and SS. Outcomes from this patient population will be compared to patients with dry eye disease.
Conditions
- Stevens-Johnson Syndrome
- Graft Versus Host Disease in Eye
- Sjogren's Syndrome
- Dry Eye
Interventions
Tangible BoostDevice
Patients will perform a monthly Tangible Boost treatment on their Hydra-PEG treated contact lenses.
PlaceboOther
Patients will perform a monthly placebo (saline) treatment on their Hydra-PEG treated contact lenses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual AcuityTime frame: 3 months
- Visual AcuityTime frame: 6 months
- Contact Lens ComfortTime frame: 3 months
5 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Boston Sight
Needham, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.